Vor Biopharma (VOR)10% owner sold ~$899K

~$899K

Approx. value · 449K sh @ $2.00

34.6M

Holds after · shares reported

Traded

Sep 9, 2025

Filed

Sep 11, 2025

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

1. Aug 25, 2025Insider10% owner sold ~$820K of VOR shares in the open market
2. Aug 26, 2025Insider10% owner sold ~$591K of VOR shares in the open market
3. Aug 27, 2025Insider10% owner sold ~$1.23M of VOR shares in the open market
4. Aug 28, 2025Insider10% owner sold ~$1.62M of VOR shares in the open market
5. Sep 3, 2025Insider10% owner sold ~$1.11M of VOR shares in the open market
6. Sep 4, 2025Insider10% owner sold ~$874K of VOR shares in the open market
7. Sep 5, 2025Insider10% owner sold ~$787K of VOR shares in the open market
8. Sep 8, 2025Insider10% owner sold ~$924K of VOR shares in the open market
9. Sep 9, 2025 · this disclosureInsider10% owner sold ~$899K of VOR shares in the open market

What came next

1. Sep 10, 2025Insider10% owner sold ~$635K of VOR shares in the open market
2. Sep 11, 2025Insider10% owner sold ~$521K of VOR shares in the open market
3. Sep 12, 2025Insider10% owner sold ~$526K of VOR shares in the open market
4. Sep 15, 2025Insider10% owner sold ~$656K of VOR shares in the open market
5. Sep 16, 2025Insider10% owner sold ~$689K of VOR shares in the open market
6. Sep 17, 2025Company filing · Form 8-K · Shareholder rights, Other newsChanged the rights of its shareholders, and reported other company news
7. Nov 2, 2025Company filing · Form 8-K · Executive change, Reg FDChanged a top executive or board member, and shared information with investors“On November 2, 2025 (the “Effective Date”), Vor Biopharma Inc. (the “Company”) and Dr. Qing Zuraw, the Company’s Chief Development Officer, entered into an amendment (the “Employment Agreement Amendment”) to Dr. Zuraw’s employment agreement with the Company dated July 17, 2025 (the “Employment Agreement”).”
8. Dec 5, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 5, 2025 (the “ Effective Date ”), the board of directors (the “ Board ”) of Vor Biopharma Inc. (the “ Company ”) approved a stock option repricing whereby the exercise price of certain outstanding options to purchase shares of the Company’s common stock (the “ Common Stock ”) under the Company’s Amended and Restated 2021 Equity Incentive Plan (“ 2021 Plan ”) and the Company’s 2023 Inducement Plan (the “…”
9. Dec 15, 2025Company filing · Form 8-K · Material agreement, Unregistered sharesChanged a top executive or board member, and signed an important agreement (and 2 more items)“On December 17, 2025, Sarah Reed, a member of the Company’s Board of Directors (the “Board”), delivered her notice of resignation to the Board, effective immediately.”
10. Dec 31, 2025Company filing · Form 8-K · Executive changeChanged a top executive or board member“On December 31, 2025, Vor Biopharma Inc. (the “Company”) entered into a separation agreement (the “Separation Agreement”) with Dr. Qing Zuraw, the Company’s Chief Development Officer, as a result of Dr. Zuraw’s decision to pursue other opportunities.”

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Vor Biopharma

For Vor Biopharma, OQRO holds 1 fund holdings report (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VOR page.

Other recent filings by Reprogrammed Interchange LLC, 10% owner

• SEC Form 4 at Vor Biopharma (VOR)Sep 19, 2025
• SEC Form 4 at Vor Biopharma (VOR)Sep 15, 2025
• SEC Form 4 at Vor Biopharma (VOR)Sep 15, 2025
• SEC Form 4 at Vor Biopharma (VOR)Sep 15, 2025
• SEC Form 4 at Vor Biopharma (VOR)Sep 11, 2025

The full history of Reprogrammed Interchange LLC, 10% owner is on the profile page.

How this filing works

• SEC Form 4
• Open-market purchase
• Rule 10b5-1 trading plans

Other disclosures at Vor Biopharma

• SEC Form 13F-HRAug 14, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 17, 2026
• SEC Form 13F-HRFeb 13, 2026
• SEC Form 13F-HRNov 14, 2025
• SEC Form 4Sep 19, 2025

Everything OQRO holds on this company is on its VOR page.